ArticleNeurochemical research2026
Nrf2 and STAT3 Pathways in Protecting Against Methylmercury-Induced Oxidative Stress in Hypothalamic Neuronal GT1-7 Cells.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Oxidative stress plays a critical role in the methylmercury (MeHg) neurotoxicity, as MeHg induces reactive oxygen species (ROS) generation and impairs antioxidant defense systems. However, the precise molecular mechanisms underlying MeHg-induced neurotoxicity remain elusive. The nuclear factor erythroid 2-related factor 2 (Nrf2) activates antioxidant defense genes in response to acute MeHg exposure. Similarly, the signal transducer and activator of transcription 3 (STAT3), a transcription factor involved in cell growth and anti-apoptotic genes, also contributes to maintaining redox homeostasis. Here, we sought to investigate the roles of Nrf2 and STAT3 in mouse hypothalamic neuronal GT1-7 cells exposed to MeHg. We inhibited STAT3 either pharmacologically with AG490 (a JAK2 inhibitor) or C188-9 (a small-molecule STAT3 SH2 domain inhibitor) or genetically using a lentivirus carrying STAT3 shRNA (vs. scramble control), in GT1-7 cells exposed to 5 µM MeHg. To further dissect the role of Nrf2, the pathway was pharmacologically inhibited using brusatol or activated with sulforaphane (SFN) in GT1-7 cells co-exposed to 5 µM MeHg. Changes in cell viability, reactive species production, and protein and gene expression were analyzed. Our findings reveal that deficits of either the Nrf2 or STAT3 pathways exacerbated MeHg-induced toxicity. Moreover, in MeHg-exposed cells, Nrf2 ablation led to increased STAT3 activity, suggesting a reciprocal and potentially compensatory responses between these two pathways in protecting against MeHg-induced oxidative stress. Our novel findings provide crucial understanding of the molecular mechanisms underlying MeHg neurotoxicity and offer insights into potential therapeutic strategies for mitigating acute MeHg-induced neurotoxicity.
Indexed as
Identifiers
42848097What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.